Perrigo Company plc (PRGO)

NYSE · Drug Manufacturers - Specialty & Generic

14.39
-0.25 (-1.71%)
Updated Sep 1, 7:56 PM ET
AI Rating
Buy
Overall Score
65
Trend
70
Momentum
88
Risk
24

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

Perrigo Company plc is trading at $14.39, down 1.71% on the session. The 50 day average sits at $11.47 and the 200 day at $12.18, which puts the stock in a downtrend. RSI is at 69.2, which reads as strong, and MACD is bullish crossover. Volume is average.

The nearest support is around $12.16 with resistance near $14.80, so that band frames the current range. Average daily movement is roughly $0.59, or about 4.1% of the share price, which is what any stop placement has to allow for. The overall health score of 65 out of 100 combines a trend score of 70, momentum of 88 and a risk score of 24.

Technical indicators

RSI (14)
69.2
strong
MACD
0.925
bullish crossover
SMA 20
13.21
SMA 50
11.47
SMA 200
12.18
downtrend
ATR (14)
0.59
avg daily range
Support
12.16
Resistance
14.80
Volume vs 20d
0.91x
average
Volatility
84.4%
annualised
1 month
+40.45%
3 months
+31.04%

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Company website

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.